Market reports, free public health charts and stories on oncology, across every category we cover.
Our markets on oncology, by category.
Worldwide reports first. Each covers 2024 history, a 2025 base year and forecasts to 2034.
Worldwide · 2024–2034
View report Healthcare ServicesWorldwide · 2024–2034
View report Healthcare ServicesWorldwide · 2024–2034
View report Healthcare ServicesWorldwide · 2024–2034
View report PharmaceuticalsWorldwide · 2024–2034
View report PharmaceuticalsWorldwide · 2024–2034
View report Digital HealthWorldwide · 2024–2034
View report OTC & NutraceuticalsWorldwide · 2024–2034
View report PharmaceuticalsWorldwide · 2024–2034
View reportLive data from public sources. The line shows the world (or US) trend.
2009–2023 · %
The chance of dying between 30 and 70 from heart disease, cancer, diabetes or chronic lung disease.
Compare places2011–2025 · trials started
Clinical trials on cancer that started each year with at least one site in the place…
Compare places2003–2017 · deaths per 100,000 people (age-adjusted)
Deaths from cancer for every 100,000 people, adjusted so states with older people can be compared…
Compare placesNamed as key players in the most of these markets.
Philips Healthcare4 markets here
F. Hoffmann-La Roche Ltd3 markets here
GE Healthcare3 markets here
Novartis AG3 markets here
Roche Diagnostics3 markets here
Siemens Healthineers3 markets here
Agilent Technologies2 markets here
Amgen Inc.2 markets here
Becton, Dickinson and Company2 markets here
bioMérieux SA2 markets here
Bristol-Myers Squibb2 markets here
Each opens the market's statistics page, with every country we cover.
Digital Health
Healthcare Services
OTC & Nutraceuticals
Pharmaceuticals
Full reports carry researched sizes, forecasts and company profiles. We also build custom studies.
Acuitas market figures are supplied with each full report. Chart data comes from the public sources named on each chart.